Peacock Karen 4
4 · IDEXX LABORATORIES INC /DE · Filed May 14, 2026
Research Summary
AI-generated summary of this filing
IDEXX (IDXX) Director Karen Peacock Receives Stock Option & DSU Awards
What Happened
Karen Peacock, a director of IDEXX Laboratories (IDXX), was granted equity awards on May 12, 2026: an option covering 525 shares and 234 deferred stock units (DSUs), for a combined 759 share-equivalents. Both grants are reported as derivative awards at $0.00 per share (no cash paid at grant).
Key Details
- Transaction date: 2026-05-12; Filing date: 2026-05-14 (timely filing).
- Reported awards: 525-share option (derivative) and 234 DSUs (derivative). Reported price: $0.00.
- Shares owned after transaction: not specified in the provided filing summary.
- Footnotes:
- F1 — The option vests in one installment on the one-year anniversary of the grant or at the 2027 annual meeting, whichever is earlier.
- F2 — Each DSU represents a contingent right to one share; DSUs vest on the same schedule as the option and are by default payable in common stock after a director’s resignation.
- Transaction code: A = Award/Grant.
Context
These awards are director compensation (not an open-market purchase or sale). The option gives the right to buy shares after vesting; DSUs are a deferred equity payment that converts to shares per the plan terms. Such grants are routine for board members and do not, by themselves, indicate a personal cash investment or an immediate change in market exposure.
Insider Transaction Report
- Award
Non-Qualified Stock Option (right-to-buy)
[F1]2026-05-12+525→ 525 totalExercise: $533.92Exp: 2036-05-11→ Common Stock (525 underlying) - Award
Deferred Stock Unit
[F2]2026-05-12+234→ 234 total→ Common Stock (234 underlying)
Footnotes (2)
- [F1]Grant of option to buy shares of Issuer common stock that vest in one installment on the one year anniversary of the date of grant or on the date of the 2027 annual meeting of shareholders, whichever event is earlier.
- [F2]Each deferred stock unit represents a contingent right to receive one share of Issuer common stock. These deferred stock units vest in one installment on the one year anniversary of the date of grant or on the date of the 2027 annual meeting of shareholders, whichever event is earlier, and by default are payable as common stock as soon as practicable following the date of the Director's resignation from the Board of Directors.